MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Incidence and etiologies of pediatric asterixis

    B.R. Aravamuthan, J.L. Waugh (Boston, MA, USA)

    Objective: To retrospectively examine the incidence and etiologies of asterixis in children evaluated at a tertiary care pediatric hospital. Background: Asterixis (negative myoclonus) is associated…
  • 2016 International Congress

    Results of the German registry of pediatric deep brain stimulation in patients with childhood-onset dyskinetic movement disorders (GEPESTIM)

    A. Koy, W. Milena, K.A.M. Pauls, A.A. Kühn, P. Krause, J. Hübl, G.H. Schneider, G. Deuschl, R. Erasmi, D. Falk, J.K. Krauss, G. Lütjens, A. Schnitzler, L. Wojtecki, J. Vesper, R. Korinthenberg, V.A. Coenen, V. Visser-Vandewalle, M. Hellmich, L. Timmermann (Cologne, Germany)

    Objective: We seek to systematically evaluate the clinical outcome of pediatric patients undergoing DBS at different stages of development. Background: Data on pediatric deep brain…
  • 2016 International Congress

    Novel mutations identified in dopamine transporter deficiency syndrome

    J. Ng, J. Zhen, K. Erreger, N.C. Oien, S. Mohammed, J.P. Linn, J. Muntadas, I. Denzler, A. Garcia Cazorla, R. Artuch, S. Pope, S.J.R. Heales, A. Galli, M.E.A. Reith, M.A. Kurian (London, United Kingdom)

    Objective: We aim to describe clinical phenotype, genotype and functional studies in a new cohort patients identified with Dopamine Transporter deficiency syndrome (DTDS). Background: Dopamine…
  • 2016 International Congress

    Clinical course and treatment of 6 children with GNAO1 mutations causing a severe, life-threatening chorea

    A. Robichaux-Viehoever, A. Ananth, Y.M. Kim, A. Hanson-Kahn, R. Cox, G. Enns, J. Strober, M. Willing, B. Schlaggar, J. Bernstein, Y. Wu (San Francisco, CA, USA)

    Objective: We describe the clinical course of 6 patients with de novo GNAO1 mutations with severe chorea, developmental delay and hypotonia, but the absence of…
  • 2016 International Congress

    Alternating hemiplegia of childhood: Movement disorders and epilepsy due to mutuations in ATP1A3

    A.P. Kleinert-Altamirano, M.O. Fiesco-Roa, K. Brockmann, E. Liebermann-Hernández, C. Marques-Lourenco (Tuxtla Gutiérrez, Mexico)

    Objective: To present 2 cases of children with genetic confirmative test of alternating hemiplejia of childhood. Background: Alternating hemiplegia of childhood (AHC) is a dominant…
  • 2016 International Congress

    Localization of basal ganglia and thalamic damage in dyskinetic cerebral palsy

    B.R. Aravamuthan, J.L. Waugh (Boston, MA, USA)

    Objective: To quantitatively consolidate published reports of deep grey matter injury in cerebral palsy to determine the patterns of injury associated with dystonia and dyskinesias.…
  • 2016 International Congress

    Spectrum of acute movement disorders in a pediatric movement disorder clinic; Malaysian experience

    T.A. Tajudin (Johor, Malaysia)

    Objective: To describe the spectrum of acute movement disorders in paediatric population encountered in a tertiary care neurology center in Malaysia for the duration of…
  • 2016 International Congress

    Beliefs and knowledge on Parkinson’s disease (PD) among people with PD, the public and traditional healers in Western Cape, South Africa

    J. Mokaya, J. Carr (Tygerberg, South Africa)

    Objective: To determine belief systems and knowledge about PD among patients with PD, among the public and among traditional healers. Background: Parkinson's disease (PD) is…
  • 2016 International Congress

    Nursing diagnoses and interventions in rehabilitation related to antiParkinsonian pharmacotherapy

    M.H.S. Tosin, B.G.R.B. Oliveira, T.R. Garcia (Rio de Janeiro, Brazil)

    Objective: To analyze the role of nurses in antiParkinsonian pharmacotherapy based on the International Classification for Nursing Practice (ICNP®). Background: Although it is considered an…
  • 2016 International Congress

    Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease

    G. Costa, M.J. Sisalli, L. Contu, A. Scorziello, M. Morelli (Cagliari, Italy)

    Objective: The main aim of the present study was to investigate whether behavioral and biochemical differences may occur between male and female old (12-month-old) transgenic…
  • « Previous Page
  • 1
  • …
  • 1694
  • 1695
  • 1696
  • 1697
  • 1698
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley